A question of balance

Nature

Volumn 430, Issue 6998, 2004, Pages 401-402

  Ramchandani, Paul ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ADOLESCENT; BEHAVIOR DISORDER; CHILD; DEPRESSION; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDUSTRY; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HUMAN; NOTE; PRESCRIPTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SIDE EFFECT; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; THOUGHT DISORDER; UNITED KINGDOM; UNITED STATES;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; CHILD; CLINICAL TRIALS; DEPRESSION; DRUG INDUSTRY; GREAT BRITAIN; HUMANS; LICENSURE; PAROXETINE; PATIENT ADVOCACY; SEROTONIN UPTAKE INHIBITORS; SUICIDE; TRUTH DISCLOSURE;

EID: 3342967836     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/430401a     Document Type: Note

References (9)

1. Aynsley-Green, A. et al. Br. Med. J. 321, 229-232 (2000).
2. Keller, M. B. et al. J. Am. Acad. Child Adolesc. Psychiatry 40, 762-772 (2001).
3. Wagner, K. D. et al. J. Am. Med. Assoc. 290, 1033-1041 (2003).
4. Whittington, C. J. et al. Lancet 363, 1341-1345 (2004).
5. Wagner, K. D. et al. Am. J. Psychiatry 161, 1079-1083 (2004).
6. http://medicines.mhra.gov.uk/ourwork/monitorsafequalmed/ safetymessages/ssrioverview_101203.htm (accessed 28/06/04).
7. Jureidini, J. N. et al. Br. Med. J. 328, 879-883 (2004).
8. Brent, D. & Birmaher, B. J. Am. Acad. Child Adolesc. Psychiatry 43, 379-380 (2004).
9. Pich, J. et al. Lancet 361, 1015-1016 (2003).